Search

everythinglearnresearchcommunity

for

Search:↓

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

5ARI treatment improves hair growth in older men with minimal side effects.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

BPH medications may increase the risk of self-harm and depression, especially in the first 18 months.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Rats had lasting erectile problems after stopping a certain medication.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Beta-sitosterol and stigmasterol might help prevent hair loss by blocking a specific enzyme.

A new method was created to test the effectiveness of Dihydrotestosterone (DHT) inhibitors, like finasteride and dutasteride, in human and fish cells. The results showed fish cells are more sensitive to these treatments, and dutasteride works better than finasteride in all tested cells.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.